<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39105048</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-5514</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Clinical medicine insights. Endocrinology and diabetes</Title><ISOAbbreviation>Clin Med Insights Endocrinol Diabetes</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 Syndrome Associated With Multiple Autoimmune Diseases (DM I-LADA, Chronic Autoimmune Thyroiditis and Pernicious Anemia): Case Report.</ArticleTitle><Pagination><StartPage>11795514241267185</StartPage><MedlinePgn>11795514241267185</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11795514241267185</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/11795514241267185</ELocationID><Abstract><AbstractText>COVID-19, a global epidemic of infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), not only initially refers to acute manifestations but also chronic symptoms known as Long COVID-19. Long COVID-19 represents a significant burden to healthcare systems worldwide. This syndrome encompasses a wide range of continuing health problems with variable durations and consequences for patients' everyday lives. A notable aspect of Long COVID-19 is the emergence of new-onset autoimmune diseases that could be triggered in predisposed patients with altered immune responses. Common autoimmune conditions that arise in post-COVID patients include autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain-Barre syndrome, etc., but with unclear evidence of associated disease occurrence. We present a case of a female rheumatoid arthritis patient who developed autoimmune thyroid disease, latent autoimmune diabetes of adults (LADA), and pernicious anemia after SARS-CoV-2 infection.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milic</LastName><ForeName>Gordana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ristic</LastName><ForeName>Masa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milosevic</LastName><ForeName>Milica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0004-6138-8819</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitovic</LastName><ForeName>Nikola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Pathophysiology, University Clinical Centre of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimitrijevic</LastName><ForeName>Ljubica</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0000-5861-3422</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jesic Petrovic</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Public Health Care Center Doboj, Doboj, Republic of Srpska, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salovic</LastName><ForeName>Bojana</ForeName><Initials>B</Initials><Identifier Source="ORCID">0009-0009-0921-1780</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Med Insights Endocrinol Diabetes</MedlineTA><NlmUniqueID>101578235</NlmUniqueID><ISSNLinking>1179-5514</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">chronic autoimmune thyroiditis</Keyword><Keyword MajorTopicYN="N">latent autoimmune diabetes in adults (LADA)</Keyword><Keyword MajorTopicYN="N">pernicious anemia</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>6</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39105048</ArticleId><ArticleId IdType="pmc">PMC11299211</ArticleId><ArticleId IdType="doi">10.1177/11795514241267185</ArticleId><ArticleId IdType="pii">10.1177_11795514241267185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Dis. 2021. Oct 3;53(10):737-54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15:869-875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022;94:54-62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661629</ArticleId><ArticleId IdType="pubmed">34427929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LM, et al.. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang KT, Hsu BC, Chen DY. Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review. Front Immunol. 2021;12:645013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994612</ArticleId><ArticleId IdType="pubmed">33777042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Zhang R, Zou H, Xie L, Zhou Z, Xiao Y. Latent autoimmune diabetes in adults (LADA): from immunopathogenesis to immunotherapy. Front Endocrinol. 2022;13:917169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350734</ArticleId><ArticleId IdType="pubmed">35937817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Prabhu P, Swaminath S, Amini SS. Development of islet antigen 2 (IA2) antibodies post-COVID-19 infection: a sign of autoimmunity or latent autoimmune diabetes mellitus in adults (LADA)? Cureus. 2023;15:e40971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10370364</ArticleId><ArticleId IdType="pubmed">37503491</ArticleId></ArticleIdList></Reference><Reference><Citation>Omotosho YB, Ying GW, Stolar M, Mallari AJ. COVID-19-induced diabetic ketoacidosis in an adult with latent autoimmune diabetes. Cureus. 2021;13:e12690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881111</ArticleId><ArticleId IdType="pubmed">33604221</ArticleId></ArticleIdList></Reference><Reference><Citation>Feghali K, Atallah J, Norman C. Manifestations of thyroid disease post COVID-19 illness: report of Hashimoto thyroiditis, Graves&#x2019; disease, and subacute thyroiditis. J Clin Transl Endocrinol Case Rep. 2021;22:100094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8387132</ArticleId><ArticleId IdType="pubmed">34462717</ArticleId></ArticleIdList></Reference><Reference><Citation>Naguib R. Potential relationships between COVID-19 and the thyroid gland: an update. J Int Med Res. 2022;50:03000605221082898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8894980</ArticleId><ArticleId IdType="pubmed">35226548</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo TH. Diagnostic difficulties in pernicious anemia. Discov Med. 2019;28:247-253.</Citation><ArticleIdList><ArticleId IdType="pubmed">32053765</ArticleId></ArticleIdList></Reference><Reference><Citation>Per&#x142;a-Kaj&#xe1;n J, Jakubowski H. COVID-19 and one-carbon metabolism. Int J Mol Sci. 2022;23:4181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9026976</ArticleId><ArticleId IdType="pubmed">35456998</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Ramos AE, Martin-Nares E, Hern&#xe1;ndez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10:3592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8700122</ArticleId><ArticleId IdType="pubmed">34944099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hileman CO, Malakooti SK, Patil N, Singer NG, McComsey GA. New-onset autoimmune disease after COVID-19. Front Immunol. 2024;15:1337406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10883027</ArticleId><ArticleId IdType="pubmed">38390319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekin A, Coskun BN, Dalkilic E, Pehlivan Y. The effects of COVID-19 infection on the mortality of patients receiving rituximab therapy. Ir J Med Sci. 2023;192:1959-1973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9579651</ArticleId><ArticleId IdType="pubmed">36258064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bournia VK, Fragoulis GE, Mitrou P, et al.. Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study. Rheumatology. 2024;63:1130-1138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10986801</ArticleId><ArticleId IdType="pubmed">37467059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>